Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin
- 1 December 1979
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 3 (4) , 217-221
- https://doi.org/10.1007/bf00254734
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumourPublished by Elsevier ,1977
- STRUCTURE-ACTIVITY ANALYSIS OF CHEMICAL AND BIOLOGICAL PARAMETERS OF CHLOROETHYL-NITROSOUREAS IN MICE1977
- PRELIMINARY-RESULTS OF PHASE-1 AND PHASE-2 CLINICAL-TRIALS OF RFCNU, A NEW NITROSOUREA SUGAR DERIVATIVE, IN DIGESTIVE-TRACT TUMORS1977
- Effectiveness of Murine Leukemia Chemotherapy According to the Immune State: Reconsideration of Correlations Between Chemotherapy, Tumour Cell Killing, and Survival TimePublished by Springer Nature ,1977
- Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.1976
- The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.1975
- Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.1975
- Synthesis of chlorozotocin, the 2-chloroethyl analog of the anticancer antibiotic streptozotocinJournal of Medicinal Chemistry, 1975
- 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.1973
- Therapy of advanced gastrointestinal cancer with the nitrosoureas.1973